Averto Medical Secures $2.1 Million NIH Grant for Diverticulitis Therapy Advancement Averto Medical has garnered a significant $2.1 million grant from the NIH to enhance its innovative therapy targeting diverticulitis, promising new treatment options for patients.

Averto Medical Secures $2.1 Million NIH Grant for Diverticulitis Therapy Advancement #USA #San_Francisco #Averto_Medical #ColoSeal #Diverticulitis

Averto Medical's ColoSeal™ Achieves FDA Breakthrough Device Designation Averto Medical has received FDA Breakthrough Device Designation for its ColoSeal™ system, enhancing recovery in colorectal surgery by eliminating temporary ostomies.

Averto Medical's ColoSeal™ Achieves FDA Breakthrough Device Designation #USA #San_Francisco #FDA #ColoSeal™ #Averto_Medical